395 related articles for article (PubMed ID: 33331468)
1. Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology.
Oliveira RAA; Baptista AF; Sá KN; Barbosa LM; Nascimento OJMD; Listik C; Moisset X; Teixeira MJ; ; Andrade DC
Arq Neuropsiquiatr; 2020; 78(11):741-752. PubMed ID: 33331468
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).
Attal N; Mazaltarine G; Perrouin-Verbe B; Albert T;
Ann Phys Rehabil Med; 2009 Mar; 52(2):124-41. PubMed ID: 19909703
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of pathophysiology and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):304-14. PubMed ID: 23033930
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.
Moisset X; Bouhassira D; Avez Couturier J; Alchaar H; Conradi S; Delmotte MH; Lanteri-Minet M; Lefaucheur JP; Mick G; Piano V; Pickering G; Piquet E; Regis C; Salvat E; Attal N
Rev Neurol (Paris); 2020 May; 176(5):325-352. PubMed ID: 32276788
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.
Moulin D; Boulanger A; Clark AJ; Clarke H; Dao T; Finley GA; Furlan A; Gilron I; Gordon A; Morley-Forster PK; Sessle BJ; Squire P; Stinson J; Taenzer P; Velly A; Ware MA; Weinberg EL; Williamson OD;
Pain Res Manag; 2014; 19(6):328-35. PubMed ID: 25479151
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological treatment of neuropathic pain].
Yeng LT
Drugs Today (Barc); 2009 Oct; 45 Suppl C():7-12. PubMed ID: 20087480
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and treatment of neuropathic pain.
Vranken JH
Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
[TBL] [Abstract][Full Text] [Related]
9. Pain responsiveness to opioids: central versus peripheral neuropathic pain.
Smith HS; Meek PD
J Opioid Manag; 2011; 7(5):391-400. PubMed ID: 22165038
[TBL] [Abstract][Full Text] [Related]
10. Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.
Matsuoka H; Tagami K; Ariyoshi K; Oyamada S; Kizawa Y; Inoue A; Koyama A
Jpn J Clin Oncol; 2019 May; 49(5):486-490. PubMed ID: 30793161
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological management of neuropathic pain].
Bouchenaki H; Bégou M; Magy L; Hajj R; Demiot C
Therapie; 2019 Dec; 74(6):633-643. PubMed ID: 31097329
[TBL] [Abstract][Full Text] [Related]
12. EFNS guidelines on pharmacological treatment of neuropathic pain.
Attal N; Cruccu G; Haanpää M; Hansson P; Jensen TS; Nurmikko T; Sampaio C; Sindrup S; Wiffen P;
Eur J Neurol; 2006 Nov; 13(11):1153-69. PubMed ID: 17038030
[TBL] [Abstract][Full Text] [Related]
13. [Drug treatment for neuropathic pain].
Attal N
Presse Med; 2008 Feb; 37(2 Pt 2):346-53. PubMed ID: 18178057
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.
Moulin DE; Clark AJ; Gilron I; Ware MA; Watson CP; Sessle BJ; Coderre T; Morley-Forster PK; Stinson J; Boulanger A; Peng P; Finley GA; Taenzer P; Squire P; Dion D; Cholkan A; Gilani A; Gordon A; Henry J; Jovey R; Lynch M; Mailis-Gagnon A; Panju A; Rollman GB; Velly A;
Pain Res Manag; 2007; 12(1):13-21. PubMed ID: 17372630
[TBL] [Abstract][Full Text] [Related]
16. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
[TBL] [Abstract][Full Text] [Related]
17. [Lacosamide and neuropathic pain, a review].
Alcántara-Montero A; Sánchez-Carnerero CI
Rev Neurol; 2016 Mar; 62(5):223-9. PubMed ID: 26916326
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.
Mu A; Weinberg E; Moulin DE; Clarke H
Can Fam Physician; 2017 Nov; 63(11):844-852. PubMed ID: 29138154
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic management of neuropathic pain: evidence-based recommendations.
Dworkin RH; O'Connor AB; Backonja M; Farrar JT; Finnerup NB; Jensen TS; Kalso EA; Loeser JD; Miaskowski C; Nurmikko TJ; Portenoy RK; Rice ASC; Stacey BR; Treede RD; Turk DC; Wallace MS
Pain; 2007 Dec; 132(3):237-251. PubMed ID: 17920770
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
